London South East | The UK's favourite investor portal.

CIC Gold never got to buy the mine and probably now has nothing but a bit of cash in a tin can. Some History.......
Overseas Market
Mogi: Barsbold Ulambayar (MPP) is the former environment minister, here's his self-profile, also behind the group that sold Khushuut to Mongolia Energy Corp. CICG trading suspension lifts today
LSE-Listed CIC Gold Proposes Reverse Take Over of Gobi Minerals
November 6 -- CIC Gold (LSE: CICG) announced a suspension of trading in the Company's shares on November 3, 2015 as the Company was in discussions regarding a proposed acquisition (the "Proposed Acquisition").
The Proposed Acquisition, if exchanged and completed, would constitute a reverse takeover under the Listing Rules. As the Company was unable to provide a full disclosure under Rule 5.6.15 of the Listing Rules, the Company requested a suspension of trading in its shares.
The Company is pleased to advise that the board of directors (the "Board") of the Company have agreed with the vendors to progress the acquisition of Gobi Minerals Limited for a consideration of £5,600,000 payable by the issue of 280,000,000 shares each with a half warrant to the vendors.
Gobi Minerals Limited collectively own a 100% interest (the "Interest") in mineral title Tsagaan Suvarga gold and copper situated in the South Gobi region of Mongolia located in the territory of Mandakh soum, Dornogovi aimag, 560 km from Ulaanbaatar city, known as Gobi Gold Project. It is located near Mongolian Alt Corporation now in production. The mineral lease has no proven reserves or resources and is considered green field.
The Proposed Acquisition will be subject to a number of conditions including due diligence, the production of a satisfactory Competent Person's Report, documentation, the raising of additional equity finance, the publication of a prospectus, the approval to the issue of new shares as consideration for the Proposed Acquisition by shareholders and Admission of the Company's enlarged share capital to the Main Market.
Board Changes and Management
HE Barsbold Ulambayar, who is an Independent Non Executive Director has been appointed Executive Director and Chief Operating Officer with immediate effect. Dr. Geoffrey P. Cowley, the previous Chief Executive, has been appointed Non Executive Technical Director.
Mr. D. Garamjav, who discovered the potential mineral resources in the lease area, will be appointed principal geologist upon the completion of the Proposed Acquisition. Mr. D. Garamjav discovered the world class Oyu Tolgoi gold copper deposit being developed by Rio Tinto/Ivanhoe.
CIC Gold has appointed Dr. Earl W. Abbott Independent Consulting Geologist to produce a Technical Competent Persons Report on the Interest. The Company then will conduct mineral asset de risk works and seek to divest its interests.
The de-risking phase may include some of the following actions:
· Compile a complete detailed technical report to Canadian NI 43-101 report;

Part2
Usual practice for a Company of our status is for the Regulator to require a Sponsor. Due to the cost involved, the fact that the prospectus is non-offering (not raising capital) and the experience of the Company’s management and Board of Directors, the Company will seek a derogation not to have a regulated Sponsor. There is no certainty the derogation will be granted. The Appointment and Sponsor review can take up to three months.

2. What is the management performance since appointment on April 15, 2020?
The Company is pleased to provide the achievements of management since their appointment which became effective from April 15, 2020 where they replaced Board control from Innovative Medicine Partners, LLC (“IMP”).
Management and the Board of Directors have focussed on implementing proper stewardship on capital raised, noting that cash of US$3,800 at the time of assuming their positions was not sufficient to pay liabilities.

The objectives of the team, consisting of new and some legacy people, were and remain to increase shareholder value by:
· Establishing a governance framework

. Addressing legacy issues / conflict-of-interest / administrative lapses

· Preparing and secure listing of the Company

· Securing funding for activities and to meet liabilities

· Securing Patents in appropriate jurisdiction

· Acquiring FDA approval

· Completing design and development of the product

The table 2 below details the Boards performance and effective use of investor funds. The average monthly burn rate (amount of expenses per month) post new management is US$65,930 compared to US$186,167 under previous management.

Tabe 2
3. What is the Company target share price?

The peer companies used for the derivative analysis by the auditor as detailed in question 1 above shows at our current progression a share price between US$2.20 TO US$36.20 with a share price volatility of 22.2% (price rise or fall)
The Companies target share price is:
I) Short term US$0.60 to $1.20
II) medium term US$2.80 to $8.50
Please note that the Warrants issued has a doubling effect on return and investors.For future tax consideration investors should seek appropriate tax advice and can use the following method of Investment return calculation:

Shares issued + warrants multiply by share price subtract money paid = investment return
For US $100,000 subscription, shares issued 344,828:

344,828 (shares) + 344,828 (warrants) x 1.20 (target share price) – 200,000 (investment plus warrant exercise) = US$627,586
(capital again after deduction of cash investment)
www.InnomedTec.com

Billy Williams Disclosure Officer/Director +1 251 786 4695 BWilliams@InnomedTec.com

Repost of the info.........courtesy of Sparty on ADVFN Part 1
This share holder up date is response to questions being asked by our shareholders:
1 What is the expected listing date?;
2 What is the management performance since appointment on April 15, 2020?;and
3. What is the expected share trading price and share holder return?

1. What is the expected listing date?
The Company’s is not permitted or unable to promote an expected listing date.
The regulatory reviews of the prospectus are largely complete save for the review of any requirement for updated financial statements. The listing timetable is now solely on the regulatory review outcomes and our response to any additional requirement that are imposed beyond the standard form prospectus that the Company has provided. The Company can disclose matters that have impacted the timing to date. Initial reviews have required ten (10) different sets of financial statements to meet regulatory acceptance given the complexity of transactions and intangible asset valuations.
The initial filing was made in January 2021.
A three-month delay in late 2021 was due to the request to calculate and disclose a cost in the financial statements for the shareholder protection provision (Top Up) against a potential share price falling below US$0.29. This required a complex derivative calculation and an analysis of the volatility of listed peer companies over the preceding two years. The Derivative Cost is disclosed in the financial statements from Q3 2021. Q3 Financial statements reviewed with the auditor is a precedent interim financial statements and has been valuable in timely filings of Q1 2022 and most recently Q2 2022.

The Company has engaged with the Regulator throughout the first quarter. Subsequent to Q1 2021, the Regulator paused review until the completion of the independent audit of the 31 December 2021 Financial Statements that was completed in May 2021. In June 2022 there was a requirement for Q1 2022 Financial Statement to be submitted. The Company at the time of this shareholder update has completed Q2 2022 Financial statements and will be filed shortly. the Regulator also requires the quarterly financial statements to be submitted with a confirmation and comfort letter from the Company auditors, again a time and cost imposition.

RSM Canada, the Company auditors, have been very focused to speed up their review processes required because of the significant judgements required in our financial statement disclosures through derivative analysis. The depth of knowledge that they now have is of great assistance to the Company’s ability to respond to the Regulator’s requirements more quickly.

The Regulator has now requested the Share Purchase Agreement (former Class two members) be updated to meet their requirements. Those affected will receive an email of changes requested by the regulators.

Email from Stuart
Dear Anthony, (my name is Ian)

Please see attached Innomed Tech Ltd updated prospectus filed today.

Prospectus filing dates are very flexible as significant milestones have are being achieved by management and needs to be included in the prospectus.

These material changes include the following:

1 Advancement of PureFlowCath prototype to near completion

2 Confirmation that PureFlowCath medical device does not require multi year clinical testing as it is an advancement on approved devices (3 year time saving to market)

3 Securitisation parties being finalised. I have attached the parties diagram and you can see CIC is way ahead in its Luxembourg operation vs. any competitors

4 Financial Statements are to 31 March 2022 and do not require updating for nine months. Please note the PureFlowCath medical device IP Financial Statements are separate to what is in the prospectus.

5 All IP has been transferred to CIC Fund Securitisation (refer to extensive list of IP in Prospectus Schedules).

6 No debt with the majority 12 month expenditure prepaid

7 CIC has raised US$ 4.1 million in equity finance since 15 April 2020 (date of CIC take over) delivered to client and reflected in Audited Financial Statements.

8 CIC Fund Securitisation S.A. has delivered first debt finance of Euro 1.1 million with Euro 8.9 m in trust account to be delivered on listing. The initial payment to cover 12 month working capital.

CIC Capital Ltd is now regulated Transaction Advisor in EU, US and Canada. The multi jurisdiction foot print has now attracted multinational corporation requiring specialist securitisation and coupled with Transaction advisory using a single provider - CIC rather that engaging different legal, accounting and other advisors focused in a particular jurisdiction.

Please contact my mobile if you require any further inputs.

Kind Regards,

Stuart J. Bromley
Mobile Global +44 (0)731 1400014
www.CICCapital.com
www.Securitisation.com
19-25, Rue des Capucins, L-1313 Luxembourg
linkedin

Latest Share Chat

Member Info for macnai

Followers

Following

Posts (Last 30 Days)

Posts (All Time)

Last Post

Member Since

Share Chat Post Distribution (Last 30 Days)

Activity Log (Last 30 Days)

Latest Share Chat

Member Info for macnai

Followers

Following

Posts (Last 30 Days)

Posts (All Time)

Last Post

Member Since

Share Chat Post Distribution (Last 30 Days)

Activity Log (Last 30 Days)

Please enter at least 2 characters

No results found

Search results

Recently viewed

Trending